Find News

Filter articles

Showing 3311 to 3320 of 3632 results

Bayer loses another Nexavar compulsory licence appeal in India

India16-07-2014Legal developments

The Mumbai High Court has upheld India-based Natco Pharma’s compulsory licence on Bayer’s kidney cancer drug Nexavar (sorafenib).

Canada responds to Lilly’s NAFTA complaint


The Canadian government has responded to Eli Lilly’s complaint that recent decisions to invalidate two Lilly patents violated the North American Free Trade Agreement, saying that Lilly’s challenge is “wholly without merit”, and should be dismissed.

Patent box key to AbbVie takeover bid for Shire

UK, US14-07-2014

The UK government’s “patent box” was a key factor behind the multi-billion pound cash-plus-shares takeover bid for the Irish-headquartered global specialty biopharmaceutical company Shire by US-based drugs company AbbVie.

J&J IP boss out of race for USPTO top job


Johnson & Johnson’s senior vice president of IP, Phil Johnson, may be out of the running for the top job at the US Patent and Trademark Office (USPTO) as the Obama administration reconsiders its choice for the role, insiders have told The Wall Street Journal.

Pfizer facing three Celebrex antitrust cases


Pfizer is facing three class actions that allege the pharmaceutical company improperly obtained a patent covering its arthritis drug Celebrex (celecoxib) and used it to force generic drug makers into settlements that delay their entry into the market, Law360 has reported.

Sanofi sues Eli Lilly to halt Lantus biosimilar

US10-07-2014Legal developments

French pharmaceutical company Sanofi has sued Eli Lilly for infringing seven patents that cover its blockbuster diabetes drug Lantus (insulin glargine).

Acorda challenges Actavis’s Ampyra generic


US-based Acorda Therapeutics has sued Actavis for infringing four patents covering its multiple sclerosis (MS) drug Ampyra (dalfampridine).

Stites & Harbison welcomes two life sciences partners


Tennessee-based law firm Stites & Harbison PLLC has expanded its IP and technology practice with the hire of life sciences partners Kelly Hollowell and Justin McNaughton.

NeuClone and Serum Institute collaborate on biosimilars

Australia, India08-07-2014

Australian biotechnology company NeuClone has signed an agreement with vaccine maker the Serum Institute of India to manufacture and supply ten biosimilar monoclonal antibody drugs around the world.

Chinese national arrested for conspiring to steal seed trade secrets


An ex-employee for a large Chinese seed production company has been arrested in the US for conspiring to steal trade secrets from US agricultural companies including Monsanto.

Showing 3311 to 3320 of 3632 results